Nelson C L, Evans R P, Blaha J D, Calhoun J, Henry S L, Patzakis M J
Department of Orthopaedic Surgery, University of Arkansas for Medical Sciences, Little Rock 72205.
Clin Orthop Relat Res. 1993 Oct(295):96-101.
A multicenter study of infected total knee and total hip arthroplasties was conducted from 1985 until 1990. Twenty-eight patients (22 total hip arthroplasties and six total knee arthroplasties) who had periprosthetic infections were treated according to a prospective, randomized protocol. After initial debridement for their infections, patients were randomized into one of the two following groups: Group I, debridement and the implantation of gentamicin-polymethylmethacrylate (PMMA) beads; and Group 2, debridement and conventional parenteral systemic antibiotic therapy. After initial treatment, the patients were then scheduled for a delayed reconstruction total joint arthroplasty. Of the 28 patients, 25 subsequently had delayed total arthroplasty, and if acrylic bone cement was used for fixation at the time of reimplantation, antibiotics were not added to the cement. The average follow-up period was three years (range, six months to 5.6 years). Infection recurred in two patients treated by debridement and the implantation of gentamicin-PMMA beads (15%) and in four patients treated with debridement and conventional systemic antibiotic therapy (30%). All recurrences occurred in patients who had infected total hip arthroplasties; none occurred in patients with total knee arthroplasties. The conditions that were common in patients with recurrent infection were (1) multiple previous surgeries, (2) host compromise and malnutrition, (3) extensive infection, and (4) inadequate debridement. The recurrence of infection was not statistically significantly more common in either treatment group. The outcome of treatment in patients with infected total joint arthroplasties using debridement, gentamicin-PMMA bead implantation,and a two-stage delayed reconstruction was similar to that of patients treated with debridement combined with conventional parenteral systemic arthroplasty and two-stage reconstruction.
1985年至1990年开展了一项关于感染性全膝关节和全髋关节置换术的多中心研究。28例发生假体周围感染的患者(22例全髋关节置换术和6例全膝关节置换术)按照前瞻性随机方案进行治疗。在对感染进行初次清创后,患者被随机分为以下两组之一:第一组,清创并植入庆大霉素-聚甲基丙烯酸甲酯(PMMA)珠;第二组,清创并进行传统的胃肠外全身抗生素治疗。初次治疗后,患者随后安排进行延迟的全关节置换术重建。28例患者中,25例随后进行了延迟全关节置换术,并且如果在再次植入时使用丙烯酸骨水泥进行固定,则不向骨水泥中添加抗生素。平均随访期为3年(范围为6个月至5.6年)。在接受清创并植入庆大霉素-PMMA珠治疗的2例患者中感染复发(15%),在接受清创和传统全身抗生素治疗的4例患者中感染复发(30%)。所有复发均发生在感染性全髋关节置换术患者中;全膝关节置换术患者中无一例复发。感染复发患者中常见的情况为:(1)既往多次手术;(2)宿主抵抗力下降和营养不良;(3)广泛感染;(4)清创不充分。感染复发在两个治疗组中均无统计学意义上的更常见情况。采用清创、庆大霉素-PMMA珠植入和两阶段延迟重建治疗感染性全关节置换术患者的治疗结果与采用清创联合传统胃肠外全身抗生素治疗和两阶段重建患者的治疗结果相似。